 |
Week in the Market - March 19, 2010
<div id="comtex-body"><pre>
% Change
------------------------------
Index Close Week YTD
------------------------------------------------------
DJIA 10741.98 1.10% 3.01%
S&P 500 ...
|
03/19/2010
|
 |
|
Teva Pharmaceutical Moving On High Volume Again (TEVA)
|
03/19/2010
|
|
|
Benzinga???s Volume Movers (CTEL, IPSU, HANS, TEVA, TRMB)
|
03/19/2010
|
|
|
Like David and Goliath: The Global GNP 30 vs. the DJIA ETF
|
03/19/2010
|
 |
|
Stocks Pause Recent Run, But DJIA Extends Streak
|
03/18/2010
|
|
|
Teva Invites Public to Listen to Webcast of Investor Meeting
|
03/18/2010
|
|
|
Teva Invites Public to Listen to Webcast of Investor Meeting
|
03/18/2010
|
 |
|
Sector Wrap: Pharmaceuticals, Financials, REITs
|
03/18/2010
|
 |
|
Teva Pharmaceuticals Wins Bid for Ratiopharm
|
03/18/2010
|
|
|
CORRECTING and REPLACING Teva to Acquire ratiopharm
|
03/18/2010
|
|
|
Benzinga???s News Roundup (SI, TEVA, CPA, BKC)
|
03/18/2010
|
|
|
Teva to Acquire ratiopharm
|
03/18/2010
|
|
|
Wall Street Breakfast: Must-Know News
|
03/18/2010
|
|
|
Teva Pharmaceuticals (TEVA) Close To Buying Ratiopharm
|
03/18/2010
|
|
|
High Conviction: The Dominant Generic Drugmaker Will Widen Its Lead
|
03/18/2010
|
|
|
Top 25 Nasdaq Stocks Ranked by Market Cap
|
03/18/2010
|
|
|
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act - Form 6-K
|
03/18/2010
|
SEC Filings |
|
Pfizer Reportedly to Bid on Ratiopharm
|
03/17/2010
|
|
|
Teva Provides Update on Generic Temodar(R)
|
03/17/2010
|
|
|
Wall Street Breakfast: Must-Know News
|
03/17/2010
|
|
|
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act - Form 6-K
|
03/17/2010
|
SEC Filings |
|
Pfizer-Ranbaxy: Could There Be Trouble Brewing?
|
03/16/2010
|
|
|
Hedge Fund Ardsley Partners Ramps Up Healthcare Holdings
|
03/15/2010
|
|
|
A New Take on China
|
03/12/2010
|
|
|
Teva Announces the Appointment of Dr. Philip Frost as Chairman of Its Board of Directors
|
03/09/2010
|
|
$1.02 (1.64%)
01:24PM (15 mins delay)
